Biotech | March 11, 2022
Moderna begins Phase 2 study of Omicron-specific bivalent booster
Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine
Moderna's Omicron-specific bivalent booster candidate combines its Omicron-specific booster candidate with its Covid-19 vaccine
The money will be donated to the United Nations Children’s Fund (UNICEF)
Over the last 35 years, Dr. Moopen – Founder Chairman and Managing Director of Aster DM Healthcare has played a phenomenal role in strengthening the healthcare delivery system in GCC
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Experts will speak about primary tumours of the nervous system and also the tumours of other body parts which get metastasized to the nervous system
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
Colchicine tablets are used for the treatment and prevention of gout. It reduces inflammation which causes pain, swelling and other symptoms of gout
As the world celebrates World Glaucoma Week (March 7-13th), Nikkhil K Masurkar, Executive Director, Entod Pharmaceuticals, an authority on eye diseases spoke to Thomas C Thottathil, Editor, indianpharmapost.com, on the seriousness of Glaucoma
A total of 21 applicants have been approved for 49 products, with the potential to utilize an incentive amount of Rs. 2541 crore
Subscribe To Our Newsletter & Stay Updated
